Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA).
Pradier L, Blanchard-Brégeon V, Bohme A, Debeir T, Menager J, Benoit P, Barneoud P, Taupin V, Bertrand P, Dugay P, Cameron B, Shi Y, Naimi S, Duchesne M, Gagnaire M, Weeden T, Travaline T, Reczek D, Khiroug L, Slaoui M, Brunel P, Fukuyama H, Ravetch J, Canton T, Cohen C. Pradier L, et al. Among authors: brunel p. Alzheimers Res Ther. 2018 Nov 28;10(1):117. doi: 10.1186/s13195-018-0447-y. Alzheimers Res Ther. 2018. PMID: 30486882 Free PMC article.
Data on synthesis, ADME and pharmacological properties and early safety pharmacology evaluation of a series of novel NURR1/NOT agonist potentially useful for the treatment of Parkinson's disease.
Malanda A, Abécassis PY, Barnéoud P, Brunel P, Taupin V, Vigé X, Lesuisse D. Malanda A, et al. Among authors: brunel p. Data Brief. 2019 May 27;27:104057. doi: 10.1016/j.dib.2019.104057. eCollection 2019 Dec. Data Brief. 2019. PMID: 31687426 Free PMC article.
Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease.
Lesuisse D, Malanda A, Peyronel JF, Evanno Y, Lardenois P, De-Peretti D, Abécassis PY, Barnéoud P, Brunel P, Burgevin MC, Cegarra C, Auger F, Dommergue A, Lafon C, Even L, Tsi J, Luc TPH, Almario A, Olivier A, Castel MN, Taupin V, Rooney T, Vigé X. Lesuisse D, et al. Among authors: brunel p. Bioorg Med Chem Lett. 2019 Apr 1;29(7):929-932. doi: 10.1016/j.bmcl.2019.01.024. Epub 2019 Jan 30. Bioorg Med Chem Lett. 2019. PMID: 30773432
A new efficient synthesis of efaroxan.
Mayer P, Brunel P, Imbert T. Mayer P, et al. Among authors: brunel p. Bioorg Med Chem Lett. 1999 Oct 18;9(20):3021-2. doi: 10.1016/s0960-894x(99)00531-4. Bioorg Med Chem Lett. 1999. PMID: 10571167
Cost-effectiveness of stepwise provisional versus systematic dual stenting strategies in patients with distal bifurcation left main stem lesions: economic analysis of the EBC MAIN trial.
Le Bras A, Hildick-Smith D, Nze Ossima A, Supplisson O, Egred M, Brunel P, Banning AP, Morice MC, Durand-Zaleski I. Le Bras A, et al. Among authors: brunel p. Open Heart. 2024 Jan 19;11(1):e002479. doi: 10.1136/openhrt-2023-002479. Open Heart. 2024. PMID: 38242557 Free PMC article.
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Landi A, Alasnag M, Heg D, Frigoli E, Malik FTN, Gomez-Blazquez I, Pourbaix S, Chieffo A, Spaulding C, Sainz F, Routledge H, Andò G, Testa L, Sciahbasi A, Contractor H, Jepson N, Mieres J, Imran SS, Noor H, Smits PC, Valgimigli M; MASTER DAPT Investigators. Landi A, et al. JAMA Cardiol. 2024 Jan 1;9(1):35-44. doi: 10.1001/jamacardio.2023.4316. JAMA Cardiol. 2024. PMID: 37991745 Clinical Trial.
Stepwise provisional versus systematic culotte for stenting of true coronary bifurcation lesions: five-year follow-up of the multicentre randomised EBC TWO Trial.
Arunothayaraj S, Behan MW, Lefèvre T, Lassen JF, Chieffo A, Stankovic G, Burzotta F, Pan M, Ferenc M, Hovasse T, Spence MS, Brunel P, Cotton JM, Cockburn J, Carrié D, Baumbach A, Maeng M, Louvard Y, Hildick-Smith D. Arunothayaraj S, et al. Among authors: brunel p. EuroIntervention. 2023 May 16;19(4):e297-304. doi: 10.4244/EIJ-D-23-00211. Online ahead of print. EuroIntervention. 2023. PMID: 37946522 Free article.
Drug-Induced Uveitis Related to Checkpoint Inhibitors and MAP-kinase Inhibitors.
Thibault T, Ben Ghezala I, Freppel R, Rajillah A, Boulay C, Brunel P, Atzenhoffer M, Auvens C, Devilliers H, Grandvuillemin A. Thibault T, et al. Among authors: brunel p. Ophthalmology. 2024 Feb;131(2):249-251. doi: 10.1016/j.ophtha.2023.10.004. Epub 2023 Oct 10. Ophthalmology. 2024. PMID: 37820932 No abstract available.
Bifurcation left main stenting with or without intracoronary imaging: Outcomes from the EBC MAIN trial.
Maznyczka A, Arunothayaraj S, Egred M, Banning A, Brunel P, Ferenc M, Hovasse T, Wlodarczak A, Pan M, Schmitz T, Silvestri M, Erglis A, Kretov E, Lassen JF, Chieffo A, Lefevre T, Burzotta F, Cockburn J, Darremont O, Stankovic G, Morice MC, Louvard Y, Hildick-Smith D; EBC MAIN (European Bifurcation Club Left Main Coronary Stent study) investigators. Maznyczka A, et al. Among authors: brunel p. Catheter Cardiovasc Interv. 2023 Sep;102(3):415-429. doi: 10.1002/ccd.30785. Epub 2023 Jul 20. Catheter Cardiovasc Interv. 2023. PMID: 37473405 Clinical Trial.
193 results